Sutro Biopharma Reports on Shareholder Vote Matters
Ticker: STRO · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1382101
| Field | Detail |
|---|---|
| Company | Sutro Biopharma, Inc. (STRO) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Sutro Biopharma held a shareholder vote on June 6th, details filed today.
AI Summary
Sutro Biopharma, Inc. filed an 8-K on June 10, 2025, reporting on matters submitted to a vote of security holders on June 6, 2025. The filing details the company's corporate actions and governance decisions.
Why It Matters
This filing provides transparency into the decisions made by Sutro Biopharma's shareholders, which can impact the company's strategic direction and governance.
Risk Assessment
Risk Level: low — This is a routine filing reporting on shareholder votes, not indicating new financial or operational risks.
Key Players & Entities
- SUTRO BIOPHARMA, INC. (company) — Registrant
- June 6, 2025 (date) — Date of earliest event reported
- June 10, 2025 (date) — Date of report
- 111 Oyster Point Blvd, South San Francisco, California, 94080 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Sutro Biopharma's security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not elaborated upon in the provided excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 6, 2025.
What is Sutro Biopharma's principal executive office address?
Sutro Biopharma's principal executive office is located at 111 Oyster Point Blvd, South San Francisco, California, 94080.
What is Sutro Biopharma's telephone number?
Sutro Biopharma's telephone number is (650) 881-6500.
What is the SEC file number for Sutro Biopharma?
The SEC file number for Sutro Biopharma is 001-38662.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding SUTRO BIOPHARMA, INC. (STRO).